Vallon Pharmaceuticals

Vallon Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. It focuses on the development and commercialization of proprietary biopharmaceutical products. The firm's primary product is Abuse-Deterrent Amphetamine Immediate and its product pipeline includes ADAIR, ADMIR, ADHD, and Narcolepsy. The company was founded by David C. Baker on January 11, 2018 and is headquartered in Philadelphia, PA.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

GRI Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapies for inflammatory, fibrotic, and autoimmune diseases. It focuses on its lead program, GRI-0621, an inhibitor of type 1 invariant Natural Killer T (iNKT) cell activity and is being developed as a novel oral therapeutic for the treatment of idiopathic pulmonary fibrosis. The company was founded in May 2009 and is headquartered in La Jolla, CA.

Combined company will operate as GRI Bio , Inc. and advance i nnovative p ipeline of Natural Killer T ( “ NKT ” ) modulating therapies for the treatment of i nflammatory, f ibrotic and a utoimmune d iseases Investment proceeds expected to fund planned operations of the combined company into mid- 2024

Vallon Pharmaceuticals Completes Merger with GRI Bio, Inc.

Vallon's b oard approves 1-for-30 r everse stock split Merger expected to close April 21, 2023 PHILADELPHIA, PA, April 20, 2023 (GLOBE NEWSWIRE) -- Vallon Pharmaceuticals, Inc. (NASDAQ: VLON) (“Vallon” or the “Company”) today announced that its stockholders have approved Proposals 1, 2, 4 and 5, related to the previously announced proposed merger with GRI Bio, Inc., a privately held biotechnology company (“GRI Bio” or “GRI”), at a special meeting of stockholders held on April 20, 2023 (the “Special Meeting”). Accordingly, at the effective time of the merger, each share of GRI's common stock, will be automatically converted into the right to receive a number of shares of Vallon's common stock equal to the exchange ratio, as calculated pursuant to the merger agreement.

Vallon Pharmaceuticals Announces Stockholder Approval of Merger with GRI Bio, Inc. and Reverse Stock Split

Board of Directors unanimously recommend Vallon stockholders to vote “ FOR ” all proposals outlined in the Company's definitive Proxy Statement (the “Proxy”) in order to close the proposed merger with GRI Bio , Inc.

Vallon Pharmaceuticals Adjourns Special Meeting of Stockholders Until April 20, 2023

Bullfrog AI Holdings Inc

Immunic Inc

Hot penny stocks to watch now. The post Best Penny Stocks For 2023?

Best Penny Stocks For 2023? 3 To Watch In March

PHILADELPHIA, PA, Feb. 24, 2023 (GLOBE NEWSWIRE) -- Vallon Pharmaceuticals, Inc. (NASDAQ: VLON), (“Vallon” or the “Company”), today reported its financial results for the fiscal year ended December 31, 2022.

Vallon Pharmaceuticals Reports Fiscal Year 2022 Financial Results

 Clene Nanomedicine

Wish

Use these tips for analyzing penny stocks in 2023 The post How to Analyze Penny Stocks for Profits  appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

How to Analyze Penny Stocks for Profits

Vallon Pharmaceuticals (NASDAQ: VLON ) stock is rising higher on Monday despite a lack of news from the clinical-stage biopharmaceutical company. Instead, it looks like heavy trading is behind today's gains.

Why Is Vallon Pharmaceuticals (VLON) Stock Up 38% Today

Biosig Technologies Inc

Hillstream Biopharma

Why investing in penny stocks in the long term could be the right choice The post The Benefits of Investing in Penny Stocks in the Long Term  appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

The Benefits of Investing in Penny Stocks in the Long Term

AMTD International Inc

Bright Green Corp

Penny stocks to watch with news this week. The post 3 Penny Stocks To Watch After Big News In February 2023 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

3 Penny Stocks To Watch After Big News In February 2023

Live video webcast on Tuesday, January 17 , 2023 at 1:00 PM ET

Vallon Pharmaceuticals and GRI Bio to Present at the Virtual Investor 2023 Companies to Watch Event

New York, New York--(Newsfile Corp. - December 27, 2022) - Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the "M&A Class Action Firm"), a national securities firm rated Top 50 in the 2018-2021 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City, is investigating Vallon Pharmaceuticals, Inc. (NASDAQ: VLON), relating to its proposed merger with GRI Bio, Inc.

SHAREHOLDER ALERT: The M&A Class Action Firm Announces the Investigation of Vallon Pharmaceuticals, Inc. - VLON

Crown ElectroKinetics

SoFi Technologies

Check out these tips for making money with penny stocks The post Making Profits With Penny Stocks, Beginners Guide appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Making Profits With Penny Stocks, Beginners Guide

NEW YORK , Dec. 15, 2022 /PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Vallon Pharmaceuticals, Inc. ("Vallon" or the "Company") (NASDAQ: VLON), in connection with the proposed merger of the Company with GRI Bio, Inc. ("GRI Bio").  Under the merger agreement, Vallon will acquire 100% of the outstanding equity interests of GRI Bio, by means of reverse triangular merger of a wholly owned subsidiary of Vallon with and into GRI Bio, with GRI Bio surviving as a wholly owned subsidiary of Vallon.

SHAREHOLDER ALERT: Weiss Law Investigates Vallon Pharmaceuticals, Inc.

Vallon Pharmaceuticals (NASDAQ: VLON ) stock is rocketing higher on Wednesday as investors react to news of a merger agreement with GRI Bio. According to a press release, GRI Bio will combine with a subsidiary of Vallon Pharmaceuticals.

Why Is Vallon Pharmaceuticals (VLON) Stock Up 95% Today?

Combined company will operate as GRI Bio and advance i nnovative p ipeline of Natural Killer T (NKT) regulating therapies for the treatment of i nflammatory, f ibrotic and a utoimmune d iseases

Vallon Pharmaceuticals and GRI Bio Enter into Merger Agreement with Goal of Advancing Innovative Pipeline of NKT Cell Regulators

PHILADELPHIA, PA, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Vallon Pharmaceuticals, Inc. (NASDAQ: VLON), (“Vallon” or the “Company”), a clinical-stage biopharmaceutical company primarily focused on the development of novel drugs that are designed to deter abuse in the treatment of central nervous system (CNS) disorders, today reported its financial results for the quarter ended September 30, 2022.

Vallon Pharmaceuticals Reports Third Quarter 2022 Financial Results

Innovative Eyewear Inc

PaxMedica Inc

SaverOne 2014 Ltd

Low float penny stocks to watch this week. The post Best Penny Stocks To Buy Now?

Best Penny Stocks To Buy Now? 4 Low Float Stocks To Watch This Week

Enjoy Technology

Mereo Biopharma Group Plc - ADR

Consider these tips for making a penny stocks watchlist right now The post How to Make a Penny Stocks Watchlist in July 2022 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

How to Make a Penny Stocks Watchlist in July 2022

Geron

Splash Beverage Group

Here are three penny stocks to watch this week The post Trending Penny Stocks For Your Watchlist Next Month  appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Trending Penny Stocks For Your Watchlist Next Month

Graybug Vision

HTG Molecular Diagnostics

Smart for Life Inc

Alaunos Therapeutics

Penny stocks to watch right now. The post Best Penny Stocks For July 2022?

Best Penny Stocks For July 2022? 5 To Watch Right Now

PHILADELPHIA, PA, May 13, 2022 (GLOBE NEWSWIRE) -- Vallon Pharmaceuticals, Inc. (NASDAQ: VLON), (“Vallon” or the “Company”), a clinical-stage biopharmaceutical company primarily focused on the development of novel drugs that are designed to deter abuse in the treatment of central nervous system (CNS) disorders, today announced that it has entered into definitive agreements with several institutional and accredited investors for the purchase and sale in a registered direct offering of 3,700,000 shares of its common stock, at a purchase price of $1.0632 per share.

Vallon Pharmaceuticals Announces $3.9 Million Registered Direct Offering

PHILADELPHIA, PA, May 11, 2022 (GLOBE NEWSWIRE) -- Vallon Pharmaceuticals, Inc. (NASDAQ: VLON), (“Vallon” or the “Company”), a clinical-stage biopharmaceutical company primarily focused on the development of novel drugs that are designed to deter abuse in the treatment of central nervous system (CNS) disorders, today announced that the Japan Patent Office has granted Patent No. 7054709 titled, “Abuse Deterrent Formulations of Amphetamine,” covering ADAIR 1 , the Company's proprietary abuse-deterrent formulation of immediate-release dextroamphetamine.

Vallon Pharmaceuticals Announces Issuance of Japanese Patent Covering Composition of Matter and Methods of Manufacturing for ADAIR

PHILADELPHIA, PA, May 09, 2022 (GLOBE NEWSWIRE) -- Vallon Pharmaceuticals, Inc. (NASDAQ: VLON), (“Vallon” or the “Company”), a clinical-stage biopharmaceutical company primarily focused on the development of novel drugs that are designed to deter abuse in the treatment of central nervous system (CNS) disorders, today reported its financial results for the quarter ended March 31, 2022 and provided a corporate update.

Vallon Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update

Blueknight Energy Partners, L.P.

Harbor Custom Development, Inc.

It's time for another breakdown of the top penny stocks that investors need to keep an eye on with the biggest movers for Friday! The post Top Penny Stocks Today: Why VLON, MITQ, HCDI, BKEP Stocks Are Soaring Friday appeared first on InvestorPlace.

Top Penny Stocks Today: Why VLON, MITQ, HCDI, BKEP Stocks Are Soaring Friday

Vallon Pharmaceuticals (VLON) stock is rocketing higher on Friday after the company announced it's considering strategic alternatives. The post Why Is Vallon Pharmaceuticals (VLON) Stock Up 90%+ Today?

News for Vallon Pharmaceuticals Stock (VLON)